Nirmal Bang 
Open an account 
| Year of Incorporation | 1996 |
| Website | http://www.nirmalbang.com |
| Phone | 022-3826 8600 |
| Exchanges enabled | NSE, BSE, MCX-SX, MCX, & NCDEX |
| Demat (NSDL/CDSL) | NSDL |
| Profit after Tax FY11/12 | - Rs 7.4 Crores |
| Profit after Tax FY12/13 | - Rs 12.4 Crores |
| Profit after Tax FY13/14 | - Rs 4.2 Crores |
| Profit after Tax FY 14/15 | - Rs 2.2 Crores |
| Profit after Tax FY 15/16 | - Rs 2.4 Crores |
| Profit after Tax FY 16/17 | Rs 1.5 Crores |
| Debt FY11/12 | 0 |
| Debt FY12/13 | 0 |
| Debt FY13/14 | Rs 10.8 Crores |
| Debt FY14/15 | 0 |
| Debt FY15/16 | 0 |
| Debt FY 16/17 | 0 |
| Profit to Equity(%) FY11/12 | (70.86) |
| Profit to Equity(%) FY12/13 | (39.28) |
| Profit to Equity(%) FY13/14 | (11.64) |
| Profit to Equity(%) FY14/15 | (7) |
| Profit to Equity(%) FY15/16 | (8) |
| Profit to Equity(%) FY16/17 | 3 |
| Balance Sheet Size FY11/12 | Rs 86.6 Crores |
| Balance Sheet Size FY12/13 | Rs 93.5 Crores |
| Balance Sheet Size FY13/14 | Rs 85.8 Crores |
| Balance Sheet Size FY14/15 | Rs 72 Crores |
| Balance Sheet Size FY15/16 | Rs 83 Crores |
| Balance Sheet Size FY16/17 | Rs 91.6 Crores |
Google trend over time
| Active clients - 2013 | 49,797 |
| Active clients - 2014 | 59,283 |
| Active clients - 2015 | 61,362 |
| Active clients - 2016 | 70,302 |
| Active clients - 2017 | 90,699 |
| Equity | 0.02% for Intraday, 0.2% for Delivery |
| Equity Futures | 0.02% of Turnover |
| Equity Options | Rs 35/lot |
| Currency Futures | 0.02% of Turnover |
| Currency Options | Rs 20/lot |
| Commodity | 0.01% of Turnover |
| Trading only | NA |
| Trading & Demat | Nil |
| Commodity | Nil |
| Equity | 0.0039% of Turnover |
| Futures | 0.0024% of Turnover |
| Options | 0.057% of Premium Turnover |
| Commodities | 0.0025% of Turnover |
| AMC charge | Rs 250/month |
| DP Transaction Charge | 0.03% with Rs 25 minimum per debit instruction |
| Offline order placing Charge | Nil |
| Software |  |
| Web/HTML 5 | |
| Mobile |  |
| Intraday | 5 Days on ODIN |
| End of Day | 5 Years on ODIN |
| Coding/Backtesting | |
| Online Trade Reports | |
| Online PNL Reports | |
| Online Contract Notes | |
| Equity | Upto 10 times for Intraday, upto 4 times for Delivery @interest |
| Equity Futures | Upto 4 times Intraday |
| Equity Options | Buying no Leverage, Shorting upto 2 times for Intraday |
| Currency Futures | Upto 3 times for Intraday |
| Currency Options | Buying no Leverage, Shorting upto 2 times for Intraday |
| Commodity | Upto 3 times for Intraday |
| Research & Tips | |
| Brokerage Calculator | |
| Margin Calculator | |
| Bracket orders & Trailing Stoploss | |
| Training & Education | |
| 3 in 1 Account | |
| Instant Fund withdrawal | |
| Relationship Managers | |
NEWS ON NIRMAL BANG
This RSS feed URL is deprecated
19 August 2018
Consumer demand, GST to help FMCG firms; valuations to remain high: Experts - Business Standard
19 August 2018
So, FMCG valuation would continue to remain high,” says Sunil Jain, head of research at Nirmal Bang Securities. Firstly, the overall consumer demand is improving, more importantly from the hinterland. It was also palpable in the June 2018 quarter ...
Gold Rate Today: Gold, silver trade mixed in morning deals - Economic Times
17 August 2018
Holdings of the largest silver-backed exchange-traded-fund(ETF), New York's iShares Silver Trust SLV, stood at 10236.28 up 58.50 tonnes, from the previous business day. Nirmal Bang Securities in its daily report says, "We expect prices to trade ...and more »
Share market update: Nifty Pharma among top sectoral gainers; Cadila surges 4% - Economic Times
17 August 2018
Nirmal Bang is positive on Aurobindo Pharma with a target price of Rs 764. Cadila Healthcare (up 3.94 per cent) was the top gainer in the index, followed by Aurobindo Pharma (up 3.07 per cent), Lupin (up 2.39 per cent) and Glenmark Pharmaceuticals (up ...and more »
RBI rejects tool used for Kotak stake dilution - Economic Times
14 August 2018
“Kotak can say that they will engage with the regulator but approving this instrument later after rejecting it now would put the RBI's credibility under the scanner,” said Manish Ostwal, senior analyst at Nirmal Bang Securities. “This rejection will ...and more »
Rupee crosses 70 in a first; are exporters a sound bet? - Economic Times
14 August 2018
Nirmal Bang is positive on Aurobindo Pharma with a target price of Rs 764. Elara Capital recommended IPCA Labs with a target price of Rs 860. It's also bullish on NIIT with a target price of Rs 138. “NIIT has transformed its revenue profile from an ...and more »
